vs

Side-by-side financial comparison of Astrana Health, Inc. (ASTH) and Lightspeed Commerce Inc. (LSPD). Click either name above to swap in a different company.

Astrana Health, Inc. is the larger business by last-quarter revenue ($950.5M vs $823.4M, roughly 1.2× Lightspeed Commerce Inc.). Astrana Health, Inc. runs the higher net margin — 0.7% vs -11.1%, a 11.8% gap on every dollar of revenue. Over the past eight quarters, Lightspeed Commerce Inc.'s revenue compounded faster (89.1% CAGR vs 53.3%).

Astrana Health, Inc. is a U.S.-based value-based healthcare services provider that primarily serves Medicare-eligible senior populations across the United States. It offers in-home primary care, chronic disease management, and care coordination services, aiming to improve patient health outcomes and reduce unnecessary medical costs.

Lightspeed Commerce is a point-of-sale and e-commerce software provider based in Montreal, Quebec, Canada. It was founded in 2005 by Dax da Silva, who was its CEO until February 2022. It has offices in Montreal, New York, Ottawa, Toronto, London, Belfast, Amsterdam, Berlin, Geneva, Ghent, Melbourne, Ulyanovsk, Yerevan and Tbilisi. It offers its services to retail, restaurant, and hospitality businesses.

ASTH vs LSPD — Head-to-Head

Bigger by revenue
ASTH
ASTH
1.2× larger
ASTH
$950.5M
$823.4M
LSPD
Higher net margin
ASTH
ASTH
11.8% more per $
ASTH
0.7%
-11.1%
LSPD
Faster 2-yr revenue CAGR
LSPD
LSPD
Annualised
LSPD
89.1%
53.3%
ASTH

Income Statement — Q4 FY2025 vs Q3 FY2026

Metric
ASTH
ASTH
LSPD
LSPD
Revenue
$950.5M
$823.4M
Net Profit
$6.6M
$-91.3M
Gross Margin
41.1%
Operating Margin
1.9%
-14.1%
Net Margin
0.7%
-11.1%
Revenue YoY
42.9%
Net Profit YoY
184.4%
EPS (diluted)
$0.12

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ASTH
ASTH
LSPD
LSPD
Q4 25
$950.5M
$823.4M
Q3 25
$956.0M
$543.3M
Q2 25
$654.8M
$266.1M
Q1 25
$620.4M
$253.4M
Q4 24
$665.2M
$679.1M
Q3 24
$478.7M
$439.4M
Q2 24
$486.3M
$209.1M
Q1 24
$404.4M
$230.2M
Net Profit
ASTH
ASTH
LSPD
LSPD
Q4 25
$6.6M
$-91.3M
Q3 25
$373.0K
$-64.7M
Q2 25
$9.4M
$-35.0M
Q1 25
$6.7M
$-575.9M
Q4 24
$-7.8M
$-131.4M
Q3 24
$16.1M
$-91.2M
Q2 24
$19.2M
$-48.7M
Q1 24
$14.8M
$-32.5M
Gross Margin
ASTH
ASTH
LSPD
LSPD
Q4 25
41.1%
Q3 25
41.0%
Q2 25
40.7%
Q1 25
44.1%
Q4 24
42.1%
Q3 24
41.9%
Q2 24
42.0%
Q1 24
43.3%
Operating Margin
ASTH
ASTH
LSPD
LSPD
Q4 25
1.9%
-14.1%
Q3 25
2.0%
-15.1%
Q2 25
3.1%
-16.6%
Q1 25
3.3%
-228.9%
Q4 24
0.1%
-23.8%
Q3 24
5.9%
-25.1%
Q2 24
6.2%
-27.9%
Q1 24
7.5%
-17.9%
Net Margin
ASTH
ASTH
LSPD
LSPD
Q4 25
0.7%
-11.1%
Q3 25
0.0%
-11.9%
Q2 25
1.4%
-13.2%
Q1 25
1.1%
-227.3%
Q4 24
-1.2%
-19.4%
Q3 24
3.4%
-20.8%
Q2 24
3.9%
-23.3%
Q1 24
3.7%
-14.1%
EPS (diluted)
ASTH
ASTH
LSPD
LSPD
Q4 25
$0.12
Q3 25
$0.01
Q2 25
$0.19
Q1 25
$0.14
$0.10
Q4 24
$-0.14
Q3 24
$0.33
Q2 24
$0.40
$-0.01
Q1 24
$0.31
$0.06

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ASTH
ASTH
LSPD
LSPD
Cash + ST InvestmentsLiquidity on hand
$429.5M
Total DebtLower is stronger
Stockholders' EquityBook value
$779.3M
Total Assets
$2.2B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ASTH
ASTH
LSPD
LSPD
Q4 25
$429.5M
Q3 25
$463.4M
Q2 25
$342.1M
Q1 25
$260.9M
Q4 24
$290.8M
Q3 24
$350.3M
Q2 24
$327.7M
Q1 24
$337.3M
Stockholders' Equity
ASTH
ASTH
LSPD
LSPD
Q4 25
$779.3M
Q3 25
$775.5M
Q2 25
$765.5M
Q1 25
$745.4M
Q4 24
$712.7M
Q3 24
$704.6M
Q2 24
$678.9M
Q1 24
$653.5M
Total Assets
ASTH
ASTH
LSPD
LSPD
Q4 25
$2.2B
Q3 25
$2.2B
Q2 25
$1.4B
Q1 25
$1.3B
Q4 24
$1.4B
Q3 24
$1.3B
Q2 24
$1.3B
Q1 24
$1.2B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ASTH
ASTH
LSPD
LSPD
Operating Cash FlowLast quarter
$-2.9M
Free Cash FlowOCF − Capex
$-6.0M
FCF MarginFCF / Revenue
-0.6%
Capex IntensityCapex / Revenue
0.3%
Cash ConversionOCF / Net Profit
-0.44×
TTM Free Cash FlowTrailing 4 quarters
$104.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ASTH
ASTH
LSPD
LSPD
Q4 25
$-2.9M
Q3 25
$10.0M
Q2 25
$90.9M
Q1 25
$16.6M
$-9.9M
Q4 24
$-10.9M
Q3 24
$34.0M
Q2 24
$23.2M
$-26.1M
Q1 24
$6.0M
$-28.5M
Free Cash Flow
ASTH
ASTH
LSPD
LSPD
Q4 25
$-6.0M
Q3 25
$7.4M
Q2 25
$89.5M
Q1 25
$13.6M
Q4 24
$-13.5M
Q3 24
$31.7M
Q2 24
$20.4M
Q1 24
$5.6M
FCF Margin
ASTH
ASTH
LSPD
LSPD
Q4 25
-0.6%
Q3 25
0.8%
Q2 25
13.7%
Q1 25
2.2%
Q4 24
-2.0%
Q3 24
6.6%
Q2 24
4.2%
Q1 24
1.4%
Capex Intensity
ASTH
ASTH
LSPD
LSPD
Q4 25
0.3%
Q3 25
0.3%
Q2 25
0.2%
Q1 25
0.5%
Q4 24
0.4%
Q3 24
0.5%
Q2 24
0.6%
Q1 24
0.1%
Cash Conversion
ASTH
ASTH
LSPD
LSPD
Q4 25
-0.44×
Q3 25
26.69×
Q2 25
9.65×
Q1 25
2.48×
Q4 24
Q3 24
2.11×
Q2 24
1.21×
Q1 24
0.40×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ASTH
ASTH

Medicare$542.4M57%
Commercial$99.1M10%
Care Delivery$92.1M10%
Care Enablement$78.9M8%
Other Third Parties$58.0M6%
Health Care Patient Service$39.8M4%
Health Care Other$25.5M3%
Other$12.1M1%
Management Service$10.3M1%

LSPD
LSPD

Segment breakdown not available.

Related Comparisons